HYAL-1 and survivin suitable urine biomarkers for bladder cancer diagnosis: Study
China: A recent study in Urology Journal has reported hyaluronidase 1 (HYAL-1) and survivin to be suitable urine biomarkers for the diagnosis of bladder cancer.
Bladder cancer is a common type of cancer that begins in the bladder cells. Biomarkers to identify bladder cancer are very important for the management of the disease. Ying Dong, Huzhou University, Huzhou Central Hospital, Huzhou, Zhejiang, China, and colleagues aimed to evaluate effective urine biomarkers for bladder cancer diagnosis.
For this purpose, the researchers conducted a meta-analysis following the guidelines of the Meta-Analyses (PRISMA) statement. Relevant studies were searched from the PubMed, Embase, and Cochrane Library databases. Heterogeneity tests were performed using Q statistics and I2 tests to determine the use of the random or fixed effects model. A direct comparison meta-analysis and network meta-analysis were conducted. The effect values are presented as odds ratios and 95% confidence intervals. Sensitivity analysis and consistency tests were performed.
Fifty-eight studies with 12,038 participants were included.
The results of the study were found to be
• Direct comparison meta-analysis was found to be statistically significant differences in bladder cancer antigen (BTA) trak vs. nuclear matrix protein 22 (NMP22), BTA stat vs. urine cytology (UC), and fluorescence in situ hybridization (FISH) vs. UC, among the sensitivity indicators.
• Among the specificity indicators, there were statistically significant differences in BTA trak vs. UC, ImmunoCyt (immunocyte) vs. NMP22, and BTA stat vs. FISH. Among the positive predictive indicators, NMP22 vs. UC, BTA stat vs. UC, and FISH vs. NMP22 showed statistically significant differences.
• Among the negative predictive indicators, the differences in FISH vs. UC, FISH vs. NMP22, and hyaluronidase 1 (HYAL-1) vs. UC were statistically significant. Among the accuracy indicators, FISH vs. NMP22, FISH vs. UC, and HYAL-1 vs. UC was found to be statistically significant differences. Network meta-analysis showed that HYAL-1, urothelial carcinoma associated 1 (UCA1) and survivin had the highest sensitivity, while UC had the lowest sensitivity.
• The specificity of UC, FISH, and HYAL-1 was the highest, while that of UCA1 was the lowest. In terms of positive predictive indicators, UC, FISH, and HYAL-1 had the highest positive predictive value, while the BTA group had the lowest positive predictive value.
• In terms of negative predictive indicators, HYAL-1, UCA1, and survivin had the highest negative predictive value, while UC had the lowest negative predictive value. In terms of accuracy indicators, HYAL-1, UCA1, and survivin had the highest accuracy, while UC had the lowest accuracy.
Dong and the team concluded, "HYAL-1 and survivin are suitable urine biomarkers for bladder cancer diagnosis."
Reference:
Dong, Y., Zhang, T., Li, X., Yu, F., Yu, H., & Shao, S. (2021). Urine Biomarkers for the Diagnosis of Bladder Cancer: a Network Meta-Analysis. Urology Journal, 18, 6254. https://doi.org/10.22037/uj.v18i.6254
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.